Both HIV and TB weaken the immunity.

What if two of the world’s deadliest infections didn’t just exist side by side—but actually helped each other become more dangerous? In fact they actually worsen each other, leading to more severe illness and higher death rates, especially in countries like India.

So Let Us See How Are They Connected:

We all know that HIV weakens the immune system by destroying CD4 cells (infection-fighting white blood cells). But these cells are very important to control TB bacteria. So when immunity drops due to AIDS, the body cannot keep TB in its “latent” (inactive or hidden) form, and it becomes an active disease again.

Studies show that people with HIV are about 20–30 times more likely to develop active TB than those without HIV. At the same time, TB infection increases inflammation in the body, which helps HIV multiply faster—speeding up the progression to AIDS.

What Does the Worldwide Data Say?

According to the WHO, around 7–8% of all TB patients globally are also HIV-positive. TB is the leading cause of death in people with HIV, responsible for nearly one-third of AIDS-related deaths.

A large global meta-analysis (2025) that included over 13 million patients confirmed that HIV–TB co-infection remains a major global burden, especially in low- and middle-income countries.

How is the Indian Picture?

India has the highest TB burden in the world, contributing to about 25% of global TB cases.Data from the Indian Council of Medical Research (ICMR) shows around 5% of TB patients in India are HIV-positive. Some studies report 10–20% prevalence of TB among HIV patients and may have an 18.9% co-infection rate. Government data (2024) reported over 32,000 people living with HIV–TB co-infection in India

Clinical Features and Risk:

In HIV patients, TB often behaves differently. Instead of only affecting the lungs, it may spread to lymph nodes, brain, abdomen, or throughout the body (disseminated TB). Patients with low CD4 counts are at highest risk. Mortality is also higher—some Indian studies report death rates up to 25% in co-infected individuals.

Conclusion:

In simple terms, HIV weakens the body, allowing TB to develop easily, while TB worsens HIV progression. An early detection, routine screening for both diseases, and combined treatment (ART + anti-TB therapy) are essential. Controlling this dual epidemic remains a major priority in both national programs and global health.

Disclaimer: This article is written by Practo for informational and educational purposes only. The content presented on this page should not be considered as a substitute for medical expertise. Please "DO NOT SELF-MEDICATE" and seek professional help regarding any health conditions or concerns. Practo will not be responsible for any act or omission arising from the interpretation of the content present on this page.